Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.’s indicative announcement regarding changes in controlling shareholder’s equity touching the 1% mark
Securities code: 603567 Securities abbreviation: Zhenbaodao Announcement number: Lin 2026-030 Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Indicative announcement regarding changes in controlling shareholder's equity touching the 1% mark
Heilongjiang Chuangda Group Co., Ltd. guarantees that the information provided to the company is true, accurate and complete, and contains no false records, misleading statements or major omissions.
The company's board of directors and all directors guarantee that the content of the announcement is consistent with the information provided by the information disclosure obligor.
Important content reminder:
Direction of change in equity Proportion increase□ Proportion decrease
☑
Total ratio before equity changes 52.89%
Total proportion after changes in equity 51.63%
Does this change violate the promise made?
Yes □ No
promise, intention, plan ☑
Whether the mandatory tender offer obligation is triggered? Yes□ No
☑
1. Basic information of information disclosure obligors and persons acting in concert
- Identity Category
Controlling shareholder/actual controller and persons acting in concert☑
□Other major shareholders with more than 5% and their persons acting in concert
Identity of investors and their persons acting in concert: The largest shareholder and its persons acting in concert (only applicable to those without controlling shareholders or actual controllers)
□Other______________
- Information of information disclosure obligor
Information disclosure obligations
Identity of the investor Unified social credit code Name of the person doing the residence
Liberation of Hulin City
Controlling shareholder/actual controller
Heilongjiang Chuangda ☑ West Street North Procuratorate
9123038156060139X7
Group Co., Ltd. □ Controlling shareholder/actual controller ☑ Baorun Company on the east side of the hospital Persons acting in concert □ Not applicable Xiangli Building 1□ Other direct shareholders Store No. 1 3. Information of persons acting in concert
There is no person acting in concert among the above-mentioned information disclosure obligors.
2. Basic situation when equity changes touch the 1% mark
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") received a notice from the company's controlling shareholder Heilongjiang Chuangda Group Co., Ltd. (hereinafter referred to as the "Chuangda Group") on April 3, 2026, and learned that the bondholders of Chuangda Group's non-public issuance of exchangeable corporate bonds to professional investors in 2023 (first phase) and non-public issuance of exchangeable corporate bonds to professional investors in 2023 (second phase) were announced on March 21, 2026. - A share exchange of 11,806,562 shares occurred on April 2, 2026, which resulted in a passive decrease in Chuangda Group's shareholding ratio. The shareholding ratio of the company was reduced from 52.89% to 51.63%. The change in equity touched an integral multiple of the 1% scale. The details are as follows:
Number of shares before change Proportion before change Number of shares after change Proportion after change Name of investor whose equity changes Method of equity change
(10,000 shares) (%) (10,000 shares) (%) Entities that directly change shareholdings during the time period:
Centralized bidding □
Block Transaction □
Heilongjiang Chuangda Collection 2026/3/21-2
49,766.5259 52.89 48,585.8697 51.63 Others: Changes in shareholding ratio due to exchange of bonds of Exchangeable Group Co., Ltd. 026/4/2
49,766.5259 52.89 48,585.8697 51.63 -- --Total
3. Other instructions
This equity change is a change in shareholding ratio caused by the exchange of Chuangda Group's exchangeable corporate bonds, and will not lead to changes in the company's controlling shareholder and actual controller.
This change in equity does not involve a tender offer.
This equity change does not involve Chuangda Group’s disclosure of equity change report, acquisition report summary, tender offer report summary, etc.
Chuangda Group's exchangeable corporate bonds are currently in the exchange period. There is uncertainty as to whether the holders of the exchangeable bonds will choose to exchange shares and the specific number and time of exchange. Investors are advised to pay attention to investment risks. If relevant equity changes occur subsequently, the company will perform its information disclosure obligations in a timely manner in accordance with laws, regulations and normative documents.
Announcement is hereby made.
Board of Directors of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. April 4, 2026